Locations:

Tag: blood cancer

December 16, 2024/Cancer/Blood Cancers

Bispecific Antibody Glofitamab Combination with Chemoimmunotherapy Safe and Effective for Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma after Initial Therapy

Optimized responses in transplant- and CAR T-cell therapy-eligible patients

November 8, 2024/Cancer/News & Insight

Study Reveals Actionable Findings for Improving CAR T-Cell Longevity in Patients with Acute Lymphoblastic Leukemia

Higher type 2 immunity observed in persistent CAR T cells

23-CNR-4198910-CQD-Hero-650×450 smoldering MM article

September 29, 2023/Cancer/Research

Watch and Wait Still a Viable Option for Many Patients with Smoldering Myeloma

Strategies and risk models are evolving for this asymptomatic condition

March 23, 2022/Cancer/Blood Cancers

Experimental Drug Shows Promise for Alleviating Myelofibrosis-Associated Anemia

Momelotinib, a new JAK inhibitor, inches closer to market approval

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Acute lymphoblastic leukemia ALL-L2 blood smear under light microscopy

February 1, 2022/Cancer/Blood Cancers

New Drug Combination Can Extend the Lives of Older Patients with Ph+ Acute Lymphoblastic Leukemia

Novel regimen may help overcome the shortcomings of traditional chemotherapy in geriatric population

April 19, 2019/Basic & Translational Science/Innovation

Driving Out Treatment Resistance: the Center of Excellence in Lymphoid Malignancies Research

Lymphocenter investigates therapeutic resistance and more

BackPage 1 of 1Next